Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
1.000 |
10 |
|
2004 |
2017 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.070 |
None |
1.000 |
7 |
|
2004 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.060 |
None |
1.000 |
6 |
|
2015 |
2019 |
Oestrogen receptor positive breast cancer
|
disease |
|
Neoplastic Process
|
510
|
58
|
0.050 |
None |
1.000 |
5 |
|
2006 |
2018 |
Early-Stage Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
142
|
7
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2008 |
Colon Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
2832
|
275
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2019 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2018 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.020 |
None |
0.500 |
2 |
|
2015 |
2019 |
estrogen receptor-negative breast cancer
|
disease |
|
Neoplastic Process
|
356
|
40
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2018 |
Familial (FPAH)
|
disease |
|
Disease or Syndrome
|
1075
|
276
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2015 |
Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2084
|
288
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2019 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2346
|
222
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2019 |
Endometrial Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1597
|
326
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Prostatic Intraepithelial Neoplasias
|
disease |
Neoplasms
|
Neoplastic Process
|
230
|
|
0.010 |
None |
< 0.001 |
1 |
|
2016 |
2016 |
Metastatic Prostate Carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
362
|
24
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
ovarian neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2542
|
757
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Cervix carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1881
|
283
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Stomach Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
3720
|
652
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Recurrent tumor
|
phenotype |
|
Neoplastic Process
|
735
|
33
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Eccrine spiradenoma
|
disease |
Neoplasms
|
Neoplastic Process
|
20
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Human papilloma virus infection
|
disease |
Infections
|
Disease or Syndrome
|
429
|
42
|
0.010 |
None |
< 0.001 |
1 |
|
2015 |
2015 |
Newly Diagnosed Childhood Ependymoma
|
disease |
Neoplasms
|
Neoplastic Process
|
144
|
3
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hereditary Breast and Ovarian Cancer Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Endocrine System Diseases
|
Neoplastic Process
|
74
|
2117
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Mammary Neoplasms, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |